Figure 1.
Tumor response to idelalisib therapy. Waterfall plot of maximum change from baseline of the sum of the products of the greatest perpendicular diameters (SPD) of lymph nodes for early-early PD (<12 months) and late-early (12-24 months) FL patients. The black dashed line represents a change of −50% and is a criterion for lymphadenopathy response.8